The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring

[1]  L. Balaj,et al.  Highly Sensitive EGFRvIII Detection in Circulating Extracellular Vesicle RNA of Glioma Patients , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  J. Griffin,et al.  Provider-perceived barriers to patient adherence to colorectal cancer screening , 2021, Preventive medicine reports.

[3]  B. Goh,et al.  Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer. , 2021, Cancer letters.

[4]  C. Hoyt.  Multiplex Immunofluorescence and Multispectral Imaging: Forming the Basis of a Clinical Test Platform for Immuno-Oncology , 2021, Frontiers in Molecular Biosciences.

[5]  W. Liao,et al.  Extracellular Vesicles in Liquid Biopsies: Potential for Disease Diagnosis , 2021, BioMed research international.

[6]  F. Bidard,et al.  Clinical utility of circulating tumor cells: an update , 2020, Molecular oncology.

[7]  T. Bauernhofer,et al.  A Multi-Analyte Approach for Improved Sensitivity of Liquid Biopsies in Prostate Cancer , 2020, Cancers.

[8]  K. Aldape,et al.  Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes , 2020, Nature Medicine.

[9]  D. Issadore,et al.  A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma , 2020, Clinical Cancer Research.

[10]  F. Lammert,et al.  Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis , 2020, Cells.

[11]  B. Carter,et al.  From Laboratory to Clinic: Translation of Extracellular Vesicle Based Cancer Biomarkers. , 2020, Methods.

[12]  B. Carter,et al.  Extracellular Vesicles in Glioblastoma Tumor Microenvironment , 2020, Frontiers in Immunology.

[13]  T. Huang,et al.  Acoustofluidic Salivary Exosome Isolation: A Liquid Biopsy Compatible Approach for Human Papillomavirus-Associated Oropharyngeal Cancer Detection. , 2019, The Journal of molecular diagnostics : JMD.

[14]  A. De Grassi,et al.  Translational Theragnostic of Ovarian Cancer: Where do we stand? , 2019, Current medicinal chemistry.

[15]  Xiaoyan Tang,et al.  Parallel Analyses of Somatic Mutations in Plasma Circulating Tumor DNA (ctDNA) and Matched Tumor Tissues in Early-Stage Breast Cancer , 2019, Clinical Cancer Research.

[16]  F. Bertucci,et al.  Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease , 2019, Cancers.

[17]  Xipeng Zhang,et al.  The role of mSEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer , 2019, BMC Cancer.

[18]  Crispin J. Miller,et al.  Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study , 2019, Nature Medicine.

[19]  S. Shchegrova,et al.  Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence , 2019, Clinical Cancer Research.

[20]  G. Schroth,et al.  Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery , 2019, Scientific Reports.

[21]  Qinghua Zhou,et al.  Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing , 2019, Front. Pharmacol..

[22]  J. Kolesar,et al.  Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology , 2019, Journal of clinical medicine.

[23]  C. Brennan,et al.  Tracking Tumor Evolution in Glioma through Liquid Biopsies of Cerebrospinal Fluid , 2018, Nature.

[24]  Y. Wan,et al.  Nanoscale extracellular vesicle-derived DNA is superior to circulating cell-free DNA for mutation detection in early-stage non-small-cell lung cancer , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  Hyungsuk K. D. Kim,et al.  Toward Exosome-Based Neuronal Diagnostic Devices , 2018, Micromachines.

[26]  Keval Patel,et al.  Enhanced detection of circulating tumor DNA by fragment size analysis , 2018, Science Translational Medicine.

[27]  W. Grody,et al.  Electric Field-Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment. , 2018, Journal of Molecular Diagnostics.

[28]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[29]  Yingye Zheng,et al.  Study Design Considerations for Cancer Biomarker Discoveries. , 2018, The journal of applied laboratory medicine.

[30]  Chern Ein Oon,et al.  Molecular targeted therapy: Treating cancer with specificity , 2018, European journal of pharmacology.

[31]  Raffaele Palmirotta,et al.  Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology , 2018, Therapeutic advances in medical oncology.

[32]  Ben S. Wittner,et al.  A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer. , 2018, Cancer discovery.

[33]  R. Plummer,et al.  Detection of circulating tumour cell clusters in human glioblastoma , 2018, British Journal of Cancer.

[34]  K. Kinzler,et al.  Serial circulating tumor DNA (ctDNA) analysis as a prognostic marker and a real-time indicator of adjuvant chemotherapy (CT) efficacy in stage III colon cancer (CC). , 2018 .

[35]  T. Schlange,et al.  ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress , 2018, Computational and structural biotechnology journal.

[36]  D. Watson,et al.  Prospective clinical study of circulating tumor cells for colorectal cancer screening. , 2018 .

[37]  A. Shaw,et al.  Tumour heterogeneity and resistance to cancer therapies , 2018, Nature Reviews Clinical Oncology.

[38]  Mingwei Li,et al.  Monitoring colorectal cancer following surgery using plasma circulating tumor DNA , 2018, Oncology letters.

[39]  Hugo A. Barrera-Saldaña,et al.  The dawn of the liquid biopsy in the fight against cancer , 2017, Oncotarget.

[40]  Wojciech Fendler,et al.  Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer , 2017, eLife.

[41]  C. Bettegowda,et al.  Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients , 2017, Neuro-oncology.

[42]  Yusuke Yamamoto,et al.  A combination of circulating miRNAs for the early detection of ovarian cancer , 2017, Oncotarget.

[43]  B. Nahed,et al.  Liquid biopsy for brain tumors , 2017, Expert review of molecular diagnostics.

[44]  Li-qiang Qian,et al.  Systematic comparison of exosomal proteomes from human saliva and serum for the detection of lung cancer. , 2017, Analytica chimica acta.

[45]  Sam Angiuoli,et al.  Direct detection of early-stage cancers using circulating tumor DNA , 2017, Science Translational Medicine.

[46]  Nina Tunariu,et al.  Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study , 2017, Gut.

[47]  Klaus Pantel,et al.  Liquid Biopsy: Current Status and Future Perspectives , 2017, Oncology Research and Treatment.

[48]  J. Loud,et al.  Cancer Screening and Early Detection in the 21st Century. , 2017, Seminars in oncology nursing.

[49]  Yaoyao Shi,et al.  Methylation analysis of SHOX2 and RASSF1A in bronchoalveolar lavage fluid for early lung cancer diagnosis. , 2017, Annals of diagnostic pathology.

[50]  R. Salazar,et al.  Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[51]  Hong-Gang Li,et al.  Identification and characterization of human testis derived circular RNAs and their existence in seminal plasma , 2016, Scientific Reports.

[52]  Joshua M. Weiss,et al.  Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. , 2016, Cancer cell.

[53]  Vincenza Conteduca,et al.  Cell-free DNA as a diagnostic marker for cancer: current insights , 2016, OncoTargets and therapy.

[54]  A. Vincent-Salomon,et al.  Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. , 2016, Clinical chemistry.

[55]  Yang Liu,et al.  Circulating tumor DNA detection in lung cancer patients before and after surgery , 2016, Scientific Reports.

[56]  A. Jemal,et al.  The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections , 2016, CA: a cancer journal for clinicians.

[57]  H. Ye,et al.  Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing , 2016, Scientific Reports.

[58]  Haihui Jiang,et al.  Circulating tumor cell is a common property of brain glioma and promotes the monitoring system , 2016, Oncotarget.

[59]  R. Strausberg,et al.  Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer , 2016, Science Translational Medicine.

[60]  B. Su,et al.  Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer , 2016, Tumor Biology.

[61]  M. Kassem,et al.  microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection , 2016, Scientific Reports.

[62]  W. Roa,et al.  MicroRNA expression profiling of sputum for the detection of early and locally advanced non-small-cell lung cancer: a prospective case-control study. , 2016, Current oncology.

[63]  Ying-Chih Chang,et al.  Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients , 2016, Scientific Reports.

[64]  M. Ethunandan,et al.  Tumour seeding after fine-needle aspiration and core biopsy of the head and neck--a systematic review. , 2016, The British journal of oral & maxillofacial surgery.

[65]  P. Krawczyk,et al.  Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients , 2016, Clinical and Translational Oncology.

[66]  Salvatore Piscuoglio,et al.  Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma , 2015, Nature Communications.

[67]  Toru Kumagai,et al.  Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA. , 2015, Clinical chemistry.

[68]  M. Daidone,et al.  Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS‐BRAF wild‐type colorectal cancer receiving cetuximab or panitumumab , 2015, International journal of cancer.

[69]  M. Schlumpberger,et al.  Characterization of RNA from Exosomes and Other Extracellular Vesicles Isolated by a Novel Spin Column-Based Method , 2015, PloS one.

[70]  Jorge S. Reis-Filho,et al.  Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer , 2015, Science Translational Medicine.

[71]  K. Zen,et al.  A Five-miRNA Panel Identified From a Multicentric Case–control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients , 2015, EBioMedicine.

[72]  Xiaoping Liu,et al.  MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer , 2015, PloS one.

[73]  R. Strausberg,et al.  Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[74]  Eduardo Andrés-León,et al.  Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection. , 2015, Clinical chemistry.

[75]  C. Bai,et al.  Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers. , 2015, Clinical lung cancer.

[76]  Massimo Bellomi,et al.  miR-Test: a blood test for lung cancer early detection. , 2015, Journal of the National Cancer Institute.

[77]  C. Dive,et al.  Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal Cancer. , 2015, Clinical colorectal cancer.

[78]  Enling Liu,et al.  Carboplatin-docetaxel-induced activity against ovarian cancer is dependent on up-regulated lncRNA PVT1. , 2015, International journal of clinical and experimental pathology.

[79]  M. Koch,et al.  Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study , 2015, British Journal of Cancer.

[80]  Jian Su,et al.  Sputum microRNA Biomarkers for Identifying Lung Cancer in Indeterminate Solitary Pulmonary Nodules , 2015, Clinical Cancer Research.

[81]  Marius Ilie,et al.  “Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease , 2014, PloS one.

[82]  T. Ross,et al.  Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia , 2014, Molecular & cellular oncology.

[83]  Hongzhe Li,et al.  A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. , 2014, Cancer cell.

[84]  A. Iafrate,et al.  Brain tumor cells in circulation are enriched for mesenchymal gene expression. , 2014, Cancer discovery.

[85]  M. Speicher,et al.  Hematogenous dissemination of glioblastoma multiforme , 2014, Science Translational Medicine.

[86]  Janusz Milanowski,et al.  Septin 9 promoter region methylation in free circulating DNA—potential role in noninvasive diagnosis of lung cancer: preliminary report , 2014, Medical Oncology.

[87]  C. la Vecchia,et al.  Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[88]  M. Choti,et al.  Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies , 2014, Science Translational Medicine.

[89]  Feng Jiang,et al.  Analysis of MicroRNAs in Sputum to Improve Computed Tomography for Lung Cancer Diagnosis , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[90]  Ash A. Alizadeh,et al.  An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage , 2013, Nature Medicine.

[91]  Bob S. Carter,et al.  miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development , 2013, PloS one.

[92]  L. Bryzgalov,et al.  Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients. , 2013, Lung cancer.

[93]  L. Liau,et al.  BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles , 2013, Molecular therapy. Nucleic acids.

[94]  H. Chung,et al.  One-step detection of circulating tumor cells in ovarian cancer using enhanced fluorescent silica nanoparticles , 2013, International journal of nanomedicine.

[95]  J. Soria,et al.  Circulating Tumor Cells in Lung Cancer , 2012, Acta Cytologica.

[96]  Scott E Kern,et al.  Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures. , 2012, Cancer research.

[97]  Jun Wang,et al.  Comparison of Epidermal Growth Factor Receptor Mutation Statuses in Tissue and Plasma in Stage I–IV Non-Small Cell Lung Cancer Patients , 2012, Respiration.

[98]  Hui Chen,et al.  Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma , 2012, Pathology.

[99]  A. Schetter,et al.  Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancer , 2012, International journal of cancer.

[100]  T. Molina,et al.  Morphological analysis of circulating tumour cells in patients undergoing surgery for non‐small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method , 2012, Cytopathology : official journal of the British Society for Clinical Cytology.

[101]  T. Molina,et al.  Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non‐small‐cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method , 2011, International journal of cancer.

[102]  T. Molina,et al.  Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker , 2010, Clinical Cancer Research.

[103]  Brigitte Rack,et al.  Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer , 2010, Breast Cancer Research.

[104]  N. Nelson.  Circulating tumor cells: will they be clinically useful? , 2010, Journal of the National Cancer Institute.

[105]  T. Siegal,et al.  Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades. , 2010, Neuro-oncology.

[106]  Larry Norton,et al.  Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.

[107]  N. Tsubota,et al.  Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer , 2009, Clinical Cancer Research.

[108]  I. Weissman,et al.  CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis , 2009, Cell.

[109]  Tarik Tihan,et al.  Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium , 2008, Cancer.

[110]  Cicek Gercel-Taylor,et al.  MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.

[111]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[112]  J. Whicher,et al.  Immunochemical Assays for Immunoglobulins , 1984, Annals of clinical biochemistry.

[113]  I. Waczulíková,et al.  The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders. , 2016, Neoplasma.

[114]  A. Bronkhorst,et al.  Characterization of the cell-free DNA released by cultured cancer cells. , 2016, Biochimica et biophysica acta.

[115]  C. Simone,et al.  Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non–small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: Pilot study results , 2015, Cancer.

[116]  C. Pineau,et al.  Identification of genital tract markers in the human seminal plasma using an integrative genomics approach. , 2013, Human reproduction.

[117]  Sota Asaga,et al.  Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. , 2011, Clinical chemistry.